Curaleaf Executive Chairman Boris Jordan [on International Business] Says Europe Is Very Early Stage Right Now; We Are Starting To See Real Acceleration Of Growth; Curleaf Becoming Meaningful; Going To Do Over $100m In Revenue, Margins Almost Up $50m In Europe Just Under; Very Positive Development; Largest Business In Us Or Arizona And Florida; Business In Portfolio North Of $200m Dollars, Which Is European Business
Portfolio Pulse from Benzinga Newsdesk
Curaleaf's Executive Chairman, Boris Jordan, highlights the company's growth in Europe, expecting over $100 million in revenue with significant margin improvements. Curaleaf is also a major player in the US, particularly in Arizona and Florida.
October 08, 2024 | 4:40 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Curaleaf is experiencing significant growth in Europe, with expected revenues over $100 million and improved margins. The company is also a major player in the US market.
Curaleaf's expansion in Europe with significant revenue expectations and margin improvements indicates strong growth potential. This positive development is likely to boost investor confidence and impact the stock price positively.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Curaleaf's growth in Europe and strong US presence could positively impact cannabis-focused ETFs like MSOS.
As Curaleaf is a significant player in the cannabis industry, its growth can positively influence cannabis-focused ETFs like MSOS, which may hold Curaleaf as part of their portfolio.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 50